Table 2.
Distribution of peripheral blood and metabolic parameters before and at the first restaging during immunotherapy
Median (range) | |
---|---|
SUVmax | |
Baseline | 13.8 (4.9–35.7) |
First restaging | 12.7 (3.6–40.6) |
SUVmean | |
Baseline | 6.0 (3.2–9.8) |
First restaging | 5.6 (3.0–8.9) |
MTV | |
Baseline | 68.0 (8.3–1772.0) |
First restaging | 91.3 (2.5–479.1) |
TLG | |
Baseline | 392.0 (31.0–2504.1) |
First restaging | 541.5 (7.6–4035.2) |
NLR | |
Baseline | 4.1 (0.81–32.0) |
First restaging | 4.9 (1.14–67.0) |
SUV standardized uptake value, MTV metabolic tumor volume, TLG total lesion glycolysis, NLR neutrophil–lymphocyte ratio